Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000294434 | SCV000336020 | uncertain significance | not provided | 2015-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001061626 | SCV001226374 | uncertain significance | Atrial septal defect 7 | 2024-01-09 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 257 of the NKX2-5 protein (p.Pro257Thr). This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with NKX2-5-related conditions. ClinVar contains an entry for this variant (Variation ID: 283727). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002503988 | SCV002817048 | uncertain significance | Atrial septal defect 7; Conotruncal heart malformations; Hypothyroidism, congenital, nongoitrous, 5; Tetralogy of Fallot; Ventricular septal defect 3; Hypoplastic left heart syndrome 2 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003165731 | SCV003858934 | uncertain significance | Cardiovascular phenotype | 2022-12-09 | criteria provided, single submitter | clinical testing | The p.P257T variant (also known as c.769C>A), located in coding exon 2 of the NKX2-5 gene, results from a C to A substitution at nucleotide position 769. The proline at codon 257 is replaced by threonine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV000294434 | SCV005370655 | uncertain significance | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |